SPEC INSPECS Group plc

1.139USD86.50 GBp · LSE-1.14%Mkt Cap: 124.36M USDP/E: —

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through…

Key Statistics

Company
Market Cap124.36M USD
Enterprise Value154.50M USD
Revenue (TTM)254.45M USD
Gross Profit130.60M USD
Net Income (TTM)-12.59M USD
Revenue/Share2.50 USD
Last Price1.139 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.7K
CountryGB
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINGB00BK6JPP03
Valuation
P/E (Trailing)—
P/E (Forward)10.34
PEG—
EV/EBITDA7.96
EV/Revenue0.61
P/S0.49
P/B1.01
EPS (TTM)-0.05 USD
EPS (Forward)0.11 USD
52W Range
0.526772% of range1.383
52W High1.383 USD
52W Low0.5267 USD
Profitability
Gross Margin51.73%
Oper. Margin4.58%
EBITDA Margin7.63%
Profit Margin-4.99%
ROE-11.99%
ROA-4.73%
ROIC4.60%
ROCE4.53%
Growth
Revenue Growth1.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF122.47K USD
CapEx (TTM)3.10M USD
FCF Margin7.67%
FCF Yield15.70%
Net Debt38.08M USD
Net Debt/EBITDA1.96
Net Debt/FCF1.95
Balance Sheet
Debt/Equity0.75
Current Ratio1.39
Quick Ratio0.75
Book Value/Sh1.13 USD
Cash/Share0.33 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.66%
Ex-Div DateSep 1, 2022
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.8230 USD
Upside (mean)-27.7%
Target Range0.8230 USD – 0.8230 USD
# Analysts1
Ownership
Shares Out.109.17M
Float—
Insiders89.25%
Institutions8.86%
Technical
SMA 501.198 (-4.9%)
SMA 2001.174 (-3.0%)
Beta1.64
S&P 52W Chg12.00%
Avg Vol (30d)7.13K
Avg Vol (10d)1.53K
Technical Indicators
RSI (14)1.4
MACD-1.3853
MACD Signal-1.3843
MACD Hist.-0.0010
BB Upper1.202 USD
BB Middle1.168 USD
BB Lower1.135 USD
BB Width5.69%
ATR (14)0.0332 USD
Vol Ratio (20d)4.14x

About INSPECS Group (LON: SPEC)

›

INSPECS Group (LON: SPEC) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 1,656 employees.

The shares were at 86.50 GBp on 19 November 2026, up 90.1% over 52 weeks. Its 52-week range is 40.00 GBp to 105.00 GBp: the price is 17.6% below the high and 116.3% above the low.

Its market capitalisation is 94.44M GBP.

INSPECS Group reports return on equity of -12.0%, an operating margin of 4.6% and revenue up 1.6% year over year.

Its debt exceeds its cash by 28.92M GBP, a debt-to-equity ratio of 0.75. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 62.50 GBp is 27.7% below the current price.